• Return to Headlines

Ocular Therapeut is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (OCUL , ENDP , COLL , OMER , AKRX )

By Nick Russo

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies in this peer group.

Ocular Therapeut (NASDAQ:OCUL ) ranks first with a gain of 5.06%; Endo Internation (NASDAQ:ENDP ) ranks second with a gain of 4.47%; and Collegium Pharma (NASDAQ:COLL ) ranks third with a gain of 2.77%.

Omeros Corp (NASDAQ:OMER ) follows with a gain of 2.32% and Akorn Inc (NASDAQ:AKRX ) rounds out the top five with a gain of 2.06%.

SmarTrend recommended that subscribers consider buying shares of Ocular Therapeut on December 14th, 2017 as our technology indicated a new Uptrend was in progress when shares hit $4.91. Since that recommendation, shares of Ocular Therapeut have risen 57.2%. We continue to monitor Ocular Therapeut for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance ocular therapeut endo internation collegium pharma omeros corp akorn inc

Ticker(s): OCUL ENDP COLL OMER AKRX